arrow
N

Najat C. Daw

the university of texas-md anderson cancer center
H指数:49
被引数:8,232

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Outcomes of adult patients with Li-Fraumeni syndrome and myeloid neoplasms

Li-Fraumeni综合征合并髓系肿瘤的成人患者预后

Cancer
IF5.1
2026-09-180
OAAI
Relapsed rhabdoid tumours and other non-nephroblastoma childhood and adolescent kidney tumours: perspectives from the HARMONICA collaboration

复发性横纹肌样肿瘤和其他非肾母细胞瘤儿童和青少年肾脏肿瘤: 口琴合作的观点

2026-01-020
PRE
Nivolumab plus ipilimumab induce hyper-progression in renal medullary carcinoma: results of a phase II trial and preclinical evidence

纳武利尤单抗联合伊匹木单抗诱导肾髓质癌发生超进展:一项II期试验结果及临床前证据

2025-11-250
OAAI
Mapping the Single-Cell Differentiation Landscape of Osteosarcoma
2024-05-221
OA
Hyperprogression due to myeloid mimicry in renal medullary carcinoma treated with nivolumab plus ipilimumab
2024-03-220
PRE
Complete loss of TP53 and RB1 is associated with complex genome and low immune infiltrate in pleomorphic rhabdomyosarcoma

多形性横纹肌肉瘤中TP53和RB1的完全缺失与复杂的基因组和低免疫浸润有关

2023-10-014
OAAI
Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression
2022-06-1332
OAAI
The androgen receptor is a therapeutic target in desmoplastic small round cell sarcoma
2022-06-0117
OAAI